|
|
| CAS番号. | 134523-01-6 |
| 化学名: | |
| 别名: | |
| 英語化学名: | ATORVASTATIN SODIUM |
| 英語别名: | ATORVASTATIN SODIUM;(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid sodium salt;[R-(R',R')]-2-(4-Fluorophenyl)-3-phenyl-4-[(phenylamino)carbonyl]-5-(1-methylethyl)-1-H-pyrrol-1-(-dihydrogen)heptanoic acid sodium |
| CBNumber: | CB2123969 |
| 分子式: | C33H34FN2NaO5 |
| 分子量: | 580.62 |
| MOL File: | 134523-01-6.mol |
|
|
|
|
ATORVASTATIN SODIUM 化学特性,用途語,生産方法 |
|
|
| ATORVASTATIN SODIUM 上流と下流の製品情報 |
原材料
|
準備製品
|
| ATORVASTATIN SODIUM 生産企業 Global( 22)Suppliers |
| 名前 | 電話番号 | ファックス番号 | 電子メール | 国籍 | 製品カタログ | 優位度 |
|
JIANGXI AIFEIMU TECHNOLOGY CO.,LTD
| +86-570-6040288, 6040289 | +86-570-6259526 | sales@afmpharm.com | CHINA |
96
|
61
|
|
Shanghai Boyle Chemical Co., Ltd.
| Mr Qiu 86-21-50182298(Domestic Market)Miss Xu 86-21-50180596(Abroad Market) | 86-21-57758967 | sales@boylechem.com | CHINA |
5604
|
55
|
|
XiaoGan ShenYuan ChemPharm co,ltd
| Tell:86-712-2580635 Mobile:15527768850、 18986454762 | 86-712-2580625 QQ:1623551145 | sales02@farchem.com | CHINA |
9844
|
52
|
|
ShangHai Biochempartner Co.,Ltd
| +86 13818785766，400-021-9906 | | gaoqing@biochempartner.com | CHINA |
1167
|
62
|
|
Shanghai Topbiochem Technology Co., Ltd
| +86-21-60341587 | +86-21-61294319 | sales@topbiochem.com | CHINA |
9691
|
58
|
|
（CSR Factory）China Skyrun Industrial CO.,ltd
| info@chinaskyrun.com | manager@chinaskyrun.com | sales@chinaskyrun.com | CHINA |
12226
|
58
|
|
UHN Shanghai Research & Development Co., Ltd.
| +86 (21) 5895-8002 | +86 (21) 5895-8628 | info@uhnshanghai.com | CHINA |
1514
|
58
|
|
Guangzhou Isun Pharmaceutical Co., Ltd
| 020-39119399 18927568969 | 020-39119999 | isunpharm@qq.com, isunpharm@hotmail.com | CHINA |
4836
|
55
|
|
Nanjing Sunlida Biological Technology Co., Ltd.
| 025-58378339 18913321387 | 025-58378339 | sales@sunlidabio.com | CHINA |
1997
|
55
|
|
GIHI CHEMICALS CO.,LTD
| 0086-571-86217390 | 0086-571-86217391 | Sales@gihichem.com | CHINA |
885
|
58
|
|
|
|
|